R1	Has_value Arg1:T3 Arg2:T2	
R2	Subsumes Arg1:T1 Arg2:T3	
*	OR T6 T7
R3	Has_value Arg1:T8 Arg2:T9	
R4	Has_qualifier Arg1:T6 Arg2:T4	
R5	Has_temporal Arg1:T6 Arg2:T5	
R6	AND Arg1:T6 Arg2:T8	
R7	Has_temporal Arg1:T12 Arg2:T11	
*	OR T13 T15
R8	Has_value Arg1:T13 Arg2:T14	
R9	Has_temporal Arg1:T13 Arg2:T17	
R10	AND Arg1:T12 Arg2:T13	
R11	AND Arg1:T21 Arg2:T20	
R12	AND Arg1:T21 Arg2:T19	
R13	Has_value Arg1:T22 Arg2:T23	
R14	Has_temporal Arg1:T22 Arg2:T24	
R15	AND Arg1:T21 Arg2:T22	
R16	Has_value Arg1:T25 Arg2:T27	
R17	Has_value Arg1:T29 Arg2:T30	
R18	Has_value Arg1:T28 Arg2:T30	
R19	Has_value Arg1:T31 Arg2:T32	
T1	Person 0 5	Adult
T2	Value 7 21	= 18 years old
T3	Person 18 21	old
T4	Qualifier 45 55	genotype 1
T5	Temporal 37 44	chronic
T6	Condition 56 59	HCV
T7	Condition 64 67	NCI
T8	Measurement 75 78	GDS
T9	Value 79 107	greater than or equal to 0.5
T11	Temporal 129 136	chronic
T12	Condition 137 150	HCV infection
T13	Measurement 205 222	anti-HCV antibody
T14	Value 192 200	positive
T15	Measurement 226 233	HCV RNA
T17	Temporal 234 268	at least 6 months before screening
T18	Non-representable 271 617	For the HIV/HCV co-infected group only, subjects must have HIV. HIV status will be obtained through self report. Self report will be confirmed at screening using a HIV-1 point of care test. In the event that point of care test and self-report are discordant, then HIV status will be confirmed by a licensed Western blot or a second antibody test.
T19	Condition 619 622	HIV
T20	Condition 623 626	HCV
T21	Condition 627 638	co-infected
T22	Measurement 672 691	HIV RNA measurement
T23	Value 692 705	<50 copies/mL
T24	Temporal 706 732	at the pre-treatment visit
T25	Measurement 735 744	Platelets
T27	Value 745 753	>150,000
T28	Measurement 755 787	Aspartate aminotransferase (AST)
T29	Measurement 788 818	Alanine aminotransferase (ALT)
T30	Value 819 845	<10x upper limit of normal
T31	Measurement 847 867	Creatinine clearance
T32	Value 868 914	>30 milliliters/minute/1.73 centimeter squared
